From Self-sufficiency
Jump to: navigation, search
Systematic (IUPAC) name
CAS Number 6443-50-1
ATC code none
PubChem CID 22951
Chemical data
Formula C19H24N2O2
Molar mass 312.406 g/mol[[Script error: No such module "String".]]
Script error: No such module "collapsible list".
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Xylamidine is a drug which acts as an antagonist at the 5HT2A receptor, and to a lesser extent at the 5HT1A receptor. It does not cross the blood brain barrier which makes it useful for blocking peripheral serotonergic responses like cardiovascular[1][2] and gastrointestinal effects,[3] without producing the central effects of 5HT2A blockade such as sedation, or interfering with the central actions of 5HT2A agonists.[4]


Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />
  1. Fuller RW, Kurz KD, Mason NR, Cohen ML. Antagonism of a peripheral vascular but not an apparently central serotonergic response by xylamidine and BW 501C67. European Journal of Pharmacology. 1986 Jun 5;125(1):71-7. PMID 3732393
  2. Dedeoğlu A, Fisher LA. Central and peripheral injections of the 5-HT2 agonist, 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane, modify cardiovascular function through different mechanisms. Journal of Pharmacology and Experimental Therapeutics. 1991 Dec;259(3):1027-34. PMID 1762059
  3. Baker BJ, Duggan JP, Barber DJ, Booth DA. Effects of dl-fenfluramine and xylamidine on gastric emptying of maintenance diet in freely feeding rats. European Journal of Pharmacology. 1988 May 20;150(1-2):137-42. PMID 3402534
  4. Dave KD, Quinn JL, Harvey JA, Aloyo VJ. Role of central 5-HT2 receptors in mediating head bobs and body shakes in the rabbit. Pharmacology, Biochemistry and Behaviour. 2004 Mar;77(3):623-9. PMID 15006475